KATHIRIA PLASCENCIA: Open Payments
NPI 1174261523 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,477 in 39 payments from 9 companies in 2025. Trend: 2023 $1,086 · 2024 $453 · 2025 $5,477
Consulting: $2,883Food & beverage: $1,301Travel & lodging: $1,293
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 8 | $4,056 |
| TG Therapeutics, Inc. | 8 | $701 |
| Novartis Pharmaceuticals Corporation | 6 | $262 |
| GENZYME CORPORATION | 3 | $157 |
| EMD Serono, Inc. | 5 | $112 |
| Biogen, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Amgen Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $14 |
Products named: Ocrevus, BRIUMVI, KESIMPTA, TYSABRI, PONVORY, VUMERITY, UPLIZNA, Ocrevus Zunovo.
Industry payments across CA — which companies pay providers there.
